Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Polyethylenimine Linear (PEI, MW 40,000): Mechanism, Benc...

    2026-01-19

    Polyethylenimine Linear (PEI, MW 40,000): Mechanism, Benchmarks & Transfection Optimization

    Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a cationic polymer that mediates DNA transfection via endocytosis in mammalian cell lines, with typical efficiencies of 60%–80% in serum-containing environments (Li et al. 2025). It condenses negatively charged DNA into nanoparticles that interact with cell surface proteoglycans, facilitating uptake (APExBIO). This reagent is validated across multiple cell types, including HEK-293, CHO-K1, and HeLa, and supports both small- and large-scale applications. The method is compatible with transient gene expression and recombinant protein production workflows. Proper storage and handling are critical to maintaining reagent performance and reproducibility.

    Biological Rationale

    Polyethylenimine Linear (PEI, MW 40,000) is a synthetic, linear polycation. Its primary use in molecular biology is to facilitate the delivery of nucleic acids into eukaryotic cells. The mechanism leverages electrostatic interactions: PEI forms complexes with the negatively charged phosphate backbone of DNA. These complexes can traverse the negatively charged cell membrane by interacting with surface proteoglycans and other anionic residues. The process increases cellular uptake, making PEI an effective DNA transfection reagent for in vitro studies (APExBIO).

    In practical research, this approach is fundamental for transient gene expression, gene function studies, and the scalable production of recombinant proteins. The robust performance of PEI, especially the linear 40 kDa form, is documented in mammalian cell lines that are widely used in both academic and industrial laboratories. The serum compatibility of the reagent further broadens its applicability, allowing transfection in standard cell culture conditions without compromising efficiency.

    Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

    PEI (MW 40,000) acts as a DNA transfection reagent by condensing DNA into positively charged nanoparticles. These nanoparticles are formed through the interaction of PEI's amine groups with the phosphate backbone of DNA, resulting in stable polyplexes. The positive surface charge of the polyplexes facilitates their association with negatively charged cell membrane components, such as heparan sulfate proteoglycans.

    Following cell surface binding, the PEI–DNA complexes are internalized predominantly via endocytosis. Once inside the cell, the "proton sponge effect" of PEI helps disrupt the endosomal membrane, releasing DNA into the cytoplasm. This process enhances the likelihood of nuclear entry and subsequent gene expression. Importantly, linear PEI is less cytotoxic than branched forms at equivalent molecular weights, contributing to a favorable balance of transfection efficiency and cell viability (Li et al. 2025).

    Evidence & Benchmarks

    • PEI (MW 40,000) consistently achieves 60%–80% transfection efficiency in HEK-293, CHO-K1, and HeLa cells under serum-containing conditions and optimized DNA:PEI ratios (Li et al. 2025).
    • Polyplexes with PEI enable transient protein expression yields of up to 200 mg/L in suspension-adapted HEK293T cells over 3–5 days at 37°C in serum-free or serum-supplemented media (Optimizing Transient Gene Expression).
    • Linear PEI (40 kDa) preserves cell viability (>85%) when used at N/P ratios of 10:1 to 20:1 in standard transfection protocols (Reimagining Transfection).
    • PEI-mediated uptake is robust in the presence of 10% fetal bovine serum, unlike lipid-based reagents that show reduced efficiency in serum (APExBIO).
    • Transfection efficiency and cytotoxicity are highly dependent on DNA:PEI ratio, cell density, and complexation time, necessitating optimization per cell line (Mechanistic Mastery).

    Applications, Limits & Misconceptions

    Polyethylenimine Linear (PEI, MW 40,000) is a versatile DNA transfection reagent for a wide spectrum of in vitro applications:

    • Transient Gene Expression: Rapid, high-yield recombinant protein production in mammalian cells.
    • Gene Function Studies: Functional genomics, RNA interference, and CRISPR/Cas9-mediated editing.
    • Large-Scale Production: Scalable to 100 L bioreactor formats for industrial protein or antibody manufacturing (product page).
    • Model Systems: Validated in commonly used lines such as HEK-293, HEK293T, CHO-K1, HepG2, and HeLa.

    Compared to existing guides for optimizing transient gene expression, this article provides structured, benchmarked claims and clarifies serum compatibility nuances not fully detailed elsewhere.

    Common Pitfalls or Misconceptions

    • Not suitable for in vivo delivery: PEI (MW 40,000) is optimized for in vitro applications and is not generally used for in vivo gene delivery due to toxicity and biodistribution limitations (Strategic Advances).
    • DNA:PEI ratio is critical: Suboptimal ratios can cause low transfection or excessive cytotoxicity.
    • Repeated freeze-thaw cycles degrade performance: Store at -20°C for long-term use, 4°C for frequent use; avoid repeated freeze-thawing (APExBIO).
    • Not all cell types respond identically: Primary cells and some sensitive lines may require alternative reagents or protocol modifications.
    • Complexation time and buffer pH matter: Variations can alter polyplex size and efficacy; always use recommended conditions.

    Workflow Integration & Parameters

    Successful use of Polyethylenimine Linear (PEI, MW 40,000) hinges on precise workflow integration:

    • Preparation: Use the product as supplied (2.5 mg/mL, 4 mL or 8 mL vials). Dilute in sterile, pH 7.0–7.4 buffer (e.g., 150 mM NaCl).
    • Complex Formation: Mix DNA and PEI at empirically optimized N/P ratios (commonly 10:1–20:1, by molar nitrogen/phosphate).
    • Incubation: Allow DNA–PEI complexes to form for 10–20 min at room temperature before addition to cells.
    • Transfection Conditions: Add complexes to cells in serum-containing or serum-free media; incubate at 37°C, 5% CO₂.
    • Scalability: Protocols are adaptable from 96-well plates to 100 L bioreactors, supporting both discovery and production workflows (Enhancing Transfection Consistency extends guidance to troubleshooting and scale-up).
    • Storage: For long-term stability, store at -20°C; for frequent use, keep at 4°C to minimize freeze–thaw cycles (APExBIO).

    Conclusion & Outlook

    Polyethylenimine Linear (PEI, MW 40,000) remains a cornerstone reagent in cell biology and molecular studies, offering reliable, high-efficiency DNA transfection across multiple cell lines and experimental scales. Its well-characterized mechanism, serum compatibility, and scalability have been validated in both peer-reviewed literature and industry practice. For researchers seeking robust, reproducible gene delivery and protein expression, the K1029 kit from APExBIO provides a high-value, evidence-backed solution. As molecular techniques evolve, PEI's established role in transient expression and disease modeling supports continued innovation in both basic and translational research. Compared to existing overviews of PEI in nanoparticle and mRNA delivery, this article emphasizes strict in vitro boundaries and structured, benchmarked use in classical transfection workflows.